Second-generation antipsychotics in children: Risks and monitoring needs

Area of Science:

• Pediatric Psychiatry
• Pharmacology
• Metabolic Health

Background:

• Autism spectrum disorder (ASD) in children can present with irritability, often requiring pharmacologic intervention.
• Second-generation antipsychotics (SGAs) are increasingly used for pediatric behavioral issues, including ASD-related irritability.
• SGAs, while effective, are associated with significant metabolic side effects in children, such as weight gain.

Purpose of the Study:

• To address the clinical dilemma of continuing or discontinuing SGAs in pediatric patients experiencing adverse metabolic effects.
• To provide guidance for family physicians on managing SGA-induced side effects in children.
• To explore strategies for mitigating weight gain and other metabolic disturbances associated with SGA use in pediatric populations.

Main Methods:

• Review of current literature and clinical guidelines regarding SGA use in children.
• Case vignette illustrating common clinical challenges with pediatric SGA treatment.
• Discussion of monitoring protocols and management strategies for metabolic side effects.

Main Results:

• SGAs demonstrate considerable efficacy in reducing irritability and improving quality of life in pediatric patients with ASD.
• Significant weight gain and increased waist size are common and concerning side effects of SGA treatment in children.
• Continued monitoring and proactive management are crucial for patients on SGAs, even when prescribed by other specialists.

Conclusions:

• Despite metabolic side effects like weight gain, the efficacy of SGAs often necessitates their continuation in pediatric patients.
• Family physicians play a vital role in monitoring patients on SGAs, adhering to established guidelines for safety and effectiveness.
• Lifestyle interventions, including education on healthy eating and physical activity, alongside potential adjunctive treatments like metformin, can help mitigate adverse metabolic effects.